Abiopharma

🔍 Webb Mark W. (Executive)

Company: J.Jill, Inc. (JILL)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 2,448 shares of Common Stock at $20.12 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 172,605.20 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,074 shares of Common Stock at $20.33 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: false | shares_owned_after: 174,679.20 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares of common stock, par value $0.01 per share ("Common Stock") of J.Jill, Inc. were sold in multiple transactions at prices ranging from $20.00 to $20.35, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission (the "Commission"), to any security holder of J.Jill, Inc., or to J.Jill, Inc., upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
• F2: The price reported in Column 4 is a weighted average price. The shares of common stock, par value $0.01 per share ("Common Stock") of J.Jill, Inc. were sold in multiple transactions at prices ranging from $20.01 to $20.75, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission (the "Commission"), to any security holder of J.Jill, Inc., or to J.Jill, Inc., upon request, full information regarding the number of shares sold at each separate price within the range set forth above.